Zixu Yuan

909 citations
27 papers · 636 indexed · h-index 13
Topics
Hepatocellular Carcinoma Treatment and Prognosis (5 papers)Effects of Radiation Exposure (5 papers)Cancer-related molecular mechanisms research (4 papers)

In The Last Decade

Zixu Yuan

27 papers receiving 634 citations

Peers

Zixu Yuan
Comparison fields: 5 of 80
  • Cancer Research 351
  • Molecular Biology 327
  • Oncology 184
  • Surgery 88
  • Pathology and Forensic Medicine 78
Replace Lingyu Han with:
Lingyu Han China
Wenqiang Xiang China
Jun Kiuchi Japan
Emanuela Dell’Aquila Italy
Yawei Yuan China
Wenbin Huang China
Jennifer Hanson Canada
Andrea Pretta Italy
Zixu Yuan relative to Lingyu Han China Lingyu Han's profile →
Citations per field
00.5×10×15×20×23.5×
Lingyu Han · 1×
Citations per year

Countries citing papers authored by Zixu Yuan

Since Specialization
Citations

This map shows the geographic impact of Zixu Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zixu Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zixu Yuan more than expected).

Fields of papers citing papers by Zixu Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zixu Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zixu Yuan. The network helps show where Zixu Yuan may publish in the future.

Co-authorship network of co-authors of Zixu Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Zixu Yuan. A scholar is included among the top collaborators of Zixu Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zixu Yuan. Zixu Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 5
3 4
4 14
5 69
6 8
7 48
8 21
9 77
10 12
11 2
12 4
13 15
14 27
15 42
16 3
17 62
18 70
19 87
20
LDL-C-lowering efficacy of the ezetimibe/simvastatin single tablet compared with atorvastatin or roslivastatin in elderly patients with hype rcholesterolemia
10

About Zixu Yuan

Zixu Yuan is a scholar working on Hepatology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 636 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Effects of Radiation Exposure (5 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (351 citations), Oncology (184 citations) and Molecular Biology (327 citations). Zixu Yuan has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Daici Chen, Qinghua Zhong, Dianke Chen, Qiyuan Qin, Zihuan Yang, Jianping Wang, Lei Wang, Beibei Ni, Xiaoyan Wang and Defeng Chen. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026